Literature DB >> 12665443

Differential of HIV prevalence in women and men who attended sexually transmitted disease clinics at HIV sentinel surveillance sites in Kenya, 1990-2001.

M R Joesoef1, B Cheluget, L H Marum, C Wandera, C A Ryan, K M DeCock, K Chebet.   

Abstract

Several studies in sub-Saharan Africa have reported that HIV prevalence in young women is higher than in young men. We used data from Kenya HIV sentinel surveillance conducted from 1990 to 2001 among sexually transmitted disease (STD) patients (15-49 years old) to investigate consistency of gender differentials over time and their risk factors. Of the 15,889 STD patients, the HIV prevalence ranged from 16.0% in 1990 to 41.8% in 1997. The odds ratios (ORs) of HIV infection for women compared to men decreased by age; women 15-24 years were nearly twice as likely as men of the same ages to be HIV infected (OR 1.7 [1.5-2.0]), but risk in those >44 years was almost equal (OR 0.8 [95% CI 0.7-1.2]). The odds of HIV infection for women compared to men were twice in unmarried patients (OR 2.1 [95% CI 1.8-2.3]). This association persisted after controlling for age groups or marital status, residence, level of education, and presence of STD syndromes. This pattern had been consistent over 12 years. Adolescent women with symptoms of STDs should be a focus for the HIV/STD intervention programmes because of their high risk for HIV.

Entities:  

Mesh:

Year:  2003        PMID: 12665443     DOI: 10.1258/095646203762869214

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  8 in total

1.  Correlates and trend of HIV prevalence among female sex workers attending sexually transmitted disease clinics in Pune, India (1993-2002).

Authors:  Radhika Brahme; Shruti Mehta; Seema Sahay; Neelam Joglekar; Manisha Ghate; Smita Joshi; Raman Gangakhedkar; Arun Risbud; Robert Bollinger; Sanjay Mehendale
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

2.  Correlates of prevalent HIV infection among adults and adolescents in the Kisumu incidence cohort study, Kisumu, Kenya.

Authors:  Anne Gumbe; Eleanor McLellan-Lemal; Deborah A Gust; Sherri L Pals; Kristen Mahle Gray; Richard Ndivo; Robert T Chen; Lisa A Mills; Timothy K Thomas
Journal:  Int J STD AIDS       Date:  2014-12-12       Impact factor: 1.359

3.  Decline in HIV prevalence among young women in Zambia: national-level estimates of trends mask geographical and socio-demographic differences.

Authors:  Nkomba Kayeyi; Knut Fylkesnes; Charles Michelo; Mpundu Makasa; Ingvild Sandøy
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

4.  Completing the public health HIV/AIDS alphabet.

Authors:  Arthur Ammann
Journal:  PLoS Med       Date:  2005-01       Impact factor: 11.069

5.  What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys.

Authors:  Drissa Sia; Yentéma Onadja; Mohammad Hajizadeh; S Jody Heymann; Timothy F Brewer; Arijit Nandi
Journal:  BMC Public Health       Date:  2016-11-03       Impact factor: 3.295

6.  Viral and Host Characteristics of Recent and Established HIV-1 Infections in Kisumu based on a Multiassay Approach.

Authors:  Newton Otecko; Seth Inzaule; Collins Odhiambo; George Otieno; Valarie Opollo; Alex Morwabe; Kennedy Were; Kenneth Ndiege; Fredrick Otieno; Andrea A Kim; Clement Zeh
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

7.  Role of survey response rates on valid inference: an application to HIV prevalence estimates.

Authors:  Miguel Marino; Marcello Pagano
Journal:  Emerg Themes Epidemiol       Date:  2018-03-05

8.  HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya.

Authors:  Pauli N Amornkul; Hilde Vandenhoudt; Peter Nasokho; Frank Odhiambo; Dufton Mwaengo; Allen Hightower; Anne Buvé; Ambrose Misore; John Vulule; Charles Vitek; Judith Glynn; Alan Greenberg; Laurence Slutsker; Kevin M De Cock
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.